Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Suppressive effects of the leaf of Terminalia catappa L. on osteoclast differentiation in vitro and bone weight loss in vivo.

Koyama T, Nakajima C, Nishimoto S, Takami M, Woo JT, Yazawa K.

J Nutr Sci Vitaminol (Tokyo). 2012;58(2):129-35.

2.

Suppressive effects of Anoectochilus formosanus extract on osteoclast formation in vitro and bone resorption in vivo.

Masuda K, Ikeuchi M, Koyama T, Yamaguchi K, Woo JT, Nishimura T, Yazawa K.

J Bone Miner Metab. 2008;26(2):123-9. doi: 10.1007/s00774-007-0810-8. Epub 2008 Feb 27.

PMID:
18301967
3.

Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.

Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S.

J Bone Miner Res. 2007 Jun;22(6):849-59.

4.

Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.

Kneissel M, Luong-Nguyen NH, Baptist M, Cortesi R, Zumstein-Mecker S, Kossida S, O'Reilly T, Lane H, Susa M.

Bone. 2004 Nov;35(5):1144-56.

PMID:
15542040
5.

The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss.

Kim TH, Jung JW, Ha BG, Hong JM, Park EK, Kim HJ, Kim SY.

J Nutr Biochem. 2011 Jan;22(1):8-15. doi: 10.1016/j.jnutbio.2009.11.002. Epub 2010 Mar 16.

PMID:
20233653
6.

Effects of ginkgo biloba on in vitro osteoblast cells and ovariectomized rat osteoclast cells.

Oh SM, Kim HR, Chung KH.

Arch Pharm Res. 2008 Feb;31(2):216-24.

PMID:
18365693
7.
8.

Omentin-1 exerts bone-sparing effect in ovariectomized mice.

Xie H, Xie PL, Luo XH, Wu XP, Zhou HD, Tang SY, Liao EY.

Osteoporos Int. 2012 Apr;23(4):1425-36. doi: 10.1007/s00198-011-1697-8. Epub 2011 Jul 14.

PMID:
21755404
9.

Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.

Wang X, Wu J, Shidoji Y, Muto Y, Ohishi N, Yagi K, Ikegami S, Shinki T, Udagawa N, Suda T, Ishimi Y.

J Bone Miner Res. 2002 Jan;17(1):91-100.

10.

Ovariectomy-induced bone loss and the hematopoietic system.

Kalu DN, Salerno E, Liu CC, Ferarro F, Arjmandi BN, Salih MA.

Bone Miner. 1993 Nov;23(2):145-61.

PMID:
8305879
13.

A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.

Ohno H, Kubo K, Murooka H, Kobayashi Y, Nishitoba T, Shibuya M, Yoneda T, Isoe T.

Mol Cancer Ther. 2006 Nov;5(11):2634-43.

14.

Inhibitory effects of the leaves of loquat (Eriobotrya japonica) on bone mineral density loss in ovariectomized mice and osteoclast differentiation.

Tan H, Furuta S, Nagata T, Ohnuki K, Akasaka T, Shirouchi B, Sato M, Kondo R, Shimizu K.

J Agric Food Chem. 2014 Jan 29;62(4):836-41. doi: 10.1021/jf402735u. Epub 2014 Jan 15.

PMID:
24404864
15.

A sequential culture approach to study osteoclast differentiation from nonadherent porcine bone marrow cells.

Scheven BA, Milne JS, Robins SP.

In Vitro Cell Dev Biol Anim. 1998 Jul-Aug;34(7):568-77.

PMID:
9719417
17.

In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.

Most W, Schot L, Ederveen A, van der Wee-Pals L, Papapoulos S, Löwik C.

J Bone Miner Res. 1995 Oct;10(10):1523-30.

PMID:
8686508
18.
19.

The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of berberine.

Li H, Miyahara T, Tezuka Y, Namba T, Suzuki T, Dowaki R, Watanabe M, Nemoto N, Tonami S, Seto H, Kadota S.

Biol Pharm Bull. 1999 Apr;22(4):391-6.

PMID:
10328560
20.

Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.

Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.

J Bone Miner Res. 2005 Sep;20(9):1659-68. Epub 2005 May 2.

Items per page

Supplemental Content

Write to the Help Desk